Results 111 to 120 of about 11,284 (188)

Fabry Disease Nephropathy: Compendium of "in vitro" and "in vivo" Renal Effects of Globotriaosylsphingosine. [PDF]

Kidney Blood Press Res
Jaurretche SPA, Del Rosal MV, Brajkovic ML, Isaac JI, Venera G, Pérez G.   +5 more
europepmc   +1 more source

Perivascular spaces and basilar artery remodeling in Fabry disease-a dual vascular pathology. [PDF]

Front Neurol
Roh J, Cheon CK, Lee SY, Baik SK, Park MG, Park KP, Ahn SH.   +6 more
europepmc   +1 more source

Correction: Correlation of retinal vascular characteristics with laboratory and ocular findings in Fabry disease: exploring ocular diagnostic biomarkers. [PDF]

Orphanet J Rare Dis
Lindziute M, Kaufeld J, Hufendiek K, Volkmann I, Brockmann D, Hosari S, Hohberger B, Mardin C, Framme C, Tode J, Hufendiek K.   +10 more
europepmc   +1 more source

Multiple inflammatory cytokines correlate with the vestibular and oculomotor dysfunction in Fabry disease: a prospective, longitudinal study. [PDF]

Front Immunol
Leng Y, Yuan Y, Zhao Y, Wang X, Ma J, Zhang X, Huang J, Hao H, Zhao G, Zhang W.   +9 more
europepmc   +1 more source

The insidious degeneration of white matter and cognitive decline in Fabry disease. [PDF]

PLoS One
Johnson JW, Baradaran H, Morgan J, Odèen H, Friel E, Bailey C, Zielinski BA, Underhill HR.   +7 more
europepmc   +1 more source

A diagnostic challenge of advanced-stage cardiac Fabry disease without left ventricular hypertrophy: a case report. [PDF]

Eur Heart J Case Rep
Suzuki M, Yoshigai Y, Hashimura H, Aiba T, Ohno S, Osue T, Eizawa H, Tanaka H.   +7 more
europepmc   +1 more source

Renoprotective effects of SGLT2 inhibitors in patients with Fabry disease. [PDF]

Mol Genet Metab Rep
Okamoto H, Goto S, Fujita M, Fujii H.
europepmc   +1 more source

Signal Peptide Engineering and Codon Optimization to Enhance α-Gal A Activity for rAAV Gene Therapy of Fabry Disease. [PDF]

J Inherit Metab Dis
He S, Yang L, Wan K, Zheng Z, Leng M, Gan C, Liu Y, Xiao L, Ye J, Chen Z, Zhou J, Valencia CA, Abuammah A, Chow HY, Dong B, Chen Y.   +15 more
europepmc   +1 more source

Patient-Centric Approach to Improve the Quality of Life and Healing Efficacy for Patients With Fabry Disease: A Grounded Theory-Based Analysis. [PDF]

J Korean Med Sci
Gwak SY, Lim HJ, Cho I, Shim CY, Kim K, Lee HJ, Son JW, Hong GR.   +7 more
europepmc   +1 more source

Fabry disease cardiomyopathy: A state-of-the-art review. [PDF]

Prog Cardiovasc Dis
Pande S, Varzideh F, Gambardella J, Jankauskas SS, Cerasuolo FA, Spinelli L, Kansakar U, De Luca A, Kurland IJ, Sidoli S, Iaccarino G, Sadoshima J, Santulli G.   +12 more
europepmc   +1 more source